Gene · 4659
Papers1,922
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,922
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of PP1c-PPP1R12A Substrates Using Kinase-Catalyzed Biotinylation to Identify Phosphatase Substrates. | ACS Omega | 2023 | 37810667 | PubTator, text mining | PubMed |
| Fluid flow shear stress and tissue remodeling-an orthodontic perspective: evidence synthesis and differential gene expression network analysis. | Front Bioeng Biotechnol | 2023 | 37795174 | PubTator, text mining | PubMed |
| S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer. | Oncogene | 2023 | 37794133 | PubTator, text mining | PubMed |
| Multiomics analyses reveal dynamic bioenergetic pathways and functional remodeling of the heart during intermittent fasting. | Elife | 2023 | 37769126 | PubTator, text mining | PubMed |
| Indoloquinazoline alkaloids suppress angiogenesis and inhibit metastasis of melanoma cells. | Bioorg Chem | 2023 | 37734192 | PubTator, text mining | PubMed |
| Pharmacotherapy in patients with vasomotor disorders. | Int J Cardiol Heart Vasc | 2023 | 37727753 | PubTator, text mining | PubMed |
| Activity Guided Azide-methyllysine Photo-trapping for Substrate Profiling of Lysine Demethylases. | J Am Chem Soc | 2023 | 37703462 | PubTator, text mining | PubMed |
| mRNA splicing is modulated by intronic microRNAs. | iScience | 2023 | 37692287 | PubTator, text mining | PubMed |
| Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics. | Int J Mol Sci | 2023 | 37686366 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified microRNA-675 advances the development of gastrointestinal stromal tumors via inhibiting myosin phosphatase targeting protein 1. | Genomics | 2023 | 37678441 | PubTator, text mining | PubMed |
| Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK Kinases. | Pharmaceuticals (Basel) | 2023 | 37630974 | PubTator, text mining | PubMed |
| A Protective Effect of Pirfenidone in Lung Fibroblast-Endothelial Cell Network via Inhibition of Rho-Kinase Activity. | Biomedicines | 2023 | 37626755 | PubTator, text mining | PubMed |
| A split-luciferase lysate-based approach to identify small-molecule modulators of phosphatase subunit interactions. | Cell Chem Biol | 2023 | 37625414 | PubTator, text mining | PubMed |
| Interactions between circRNAs and miR-141 in Cancer: From Pathogenesis to Diagnosis and Therapy. | Int J Mol Sci | 2023 | 37511619 | PubTator, text mining | PubMed |
| Pim Kinases: Important Regulators of Cardiovascular Disease. | Int J Mol Sci | 2023 | 37511341 | PubTator, text mining | PubMed |
| Current progress in genomics and targeted therapies for neurofibromatosis type 2. | Fukushima J Med Sci | 2023 | 37468280 | PubTator, text mining | PubMed |
| Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma. | PLoS One | 2023 | 37467193 | PubTator, text mining | PubMed |
| Mechanisms of Coronary Artery Spasm. | Eur Cardiol | 2023 | 37456775 | PubTator, text mining | PubMed |
| Advances in the protein‑encoding functions of circular RNAs associated with cancer (Review). | Oncol Rep | 2023 | 37449515 | PubTator, text mining | PubMed |
| "DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies. | Front Oncol | 2023 | 37448521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4659/papers?page=7